Veinwave™ is shown to delegates at Inaugural Phlebology Meeting in Colorado

Veinwave™ was selected as one of five industry leaders to present it's revolutionary non-invasivevein removal technology at the Inaugural Phlebology Meeting held at The Peaks Resort &Golden Door Spa in Telluride, Colo., in December 2009. The companies were hand-selected onthe basis of safety, efficacy, and proven results. The Veinwave™ is the world's most advancedtreatment for effective removal of unwanted spider veins and telangiectasia. Developed by Dr.Brian Newman, an internationally-acclaimed vascular surgeon based in the United Kingdom,Veinwave has been used for nearly a decade by over 1,000 physicians in Europe. Veinwave recently received 510k clearance from the FDA to market in the USA.

(PRWEB) January 5, 2010 -- Veinwave™ was selected as one of five industry leaders to present its revolutionaryvein removal technology at the Inaugural Phlebology Meeting held at The Peaks Resort & Golden Door Spa inTelluride, Colo., in December 2009. The companies were hand-selected on the basis of safety, efficacy, andproven results.

The meeting was the brain-child of John R. Kingsley, M.D. and James H. Isobe, M.D, founders of the AlabamaPhlebology Training Institute. Dr. Kingsley is president and CEO of the Alabama and Atlanta Vascular & VeinCenters located in Birmingham, AL. and Atlanta, GA. The Atlanta and Alabama Vascular & Vein Centers areconsidered by many to be two of the highest quality specialty centers in the United States. "The purpose of theconference was to allow vascular physicians from around the world to learn about breaking news vein removaltechnology and participate in discussions with their peers," Kingsley says. Dr. John Kingsley is doubly BoardCertified by the American Board of Surgery as a board certified vascular surgeon and a board certifiedphlebologist, and one of the original physicians in the U.S. to develop and practice modern vein treatmentmethods. Board Certification in vascular surgery in the U.S. is considered a special credential and only some3,000 surgeons have qualified and successfully completed the requirements and the examinations to date. Dr.Kingsley is also one of the few certified Veinwave™ Trainers in the US.

Dr. Kingsley has performed more than 5,000 endovenous ablation operations and he and his colleagues haveperformed more than 8,000 such procedures. His Alabama Phlebology Training Institute is one of the premiertraining centers in the U.S. where other physicians and support staff learn the modern vein treatment methods.

In 2009, Dr. Kingsley was selected President of the Alabama Vascular Society, an honor he will fulfill until2011. He is past President of the American Society of Outpatient Surgeons, and Chairman of the Surgery Dept. ofCarraway Medical Center in Birmingham. He is a selected Fellow of the American Society of Vascular Surgeryand the Southern Association of Vascular Surgeons. He is the primary U.S. consultant for the Tokyo Vein Clinic,and in 2007 was selected to the Australasian College of Phlebology as an Emeritus Fellow. He achieved the rankof Commander in the U.S. Navy, and was awarded the prestigious honorable discharge upon his completion ofservice. He has been chosen one of the top surgeons in the U.S. for the past 7 years by the Consumers ResearchCouncil of America of Washington, D.C. He is the author of over 70 publications and presentations regarding hisexpertise in vascular and vein surgery.

About Veinwave™

The Veinwave™ is the world's most advanced treatment for effective removal of unwanted spider veins andtelangiectasia. Developed by Dr. Brian Newman, an internationally-acclaimed vascular surgeon based in theUnited Kingdom, Veinwave has been used for nearly a decade by over 1,000 physicians in Europe. Veinwave™recently received 510k clearance from the FDA to market in the USA. An independent six-year study fromGeorges Pompidou Hospital documents the safety and effectiveness of this proprietary system with no sideeffects.

Veinwave™ uses a revolutionary process called Unipolar Thermo-Coagulation (UTC), wherein a uniquelocalized energy is applied to the skin on top of the affected area, causing the vein walls to collapse and the veinto disappear instantly. Vein removal with the Veinwave™ provides safe, quick, and dramatic reduction ofunwanted veins on any skin type, including ethnic and dark-skinned individuals. The technology significantlyminimizes pain and the risks of bruising, burning, scaring and pigmentation changes that are associated withalternative treatments such as lasers and other light based systems. As a result, Veinwave™ has become thetreatment of choice for practitioners and patients alike, providing a relatively painless walk-in/walk-out procedurewith no bandages nor post-procedure care. Patients can resume regular activities and normal sun exposureimmediately following treatment.

The Veinwave™ system was recently purchased by the CardioVascular Institute (CVI) at Beth Israel DeaconessMedical Center, a teaching hospital of Harvard Medical School. CVI is the first Boston health care organization topurchase the revolutionary Veinwave™ system.

For more information, visit www.VeinwaveUSA.com or call (205) 427-9323.